Synlogic is bringing the transformational potential of synthetic biology to medicine. Synlogic’s pipeline includes Synthetic Biotic medicines for the treatment of Phenylketonuria (PKU), Enteric hyperoxaluria, and solid tumors. In addition, the company is leveraging the broad potential of its platform to create Synthetic Biotic medicines for the treatment of other diseases, such as inflammatory and immune disorders.